FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308310437> ?p ?o ?g. }

• W4308310437 endingPage "100520" @default.
• W4308310437 startingPage "100520" @default.
• W4308310437 abstract "Examine how innate bladder contractility and corresponding receptor expression was affected by chronic prostatitis (CP) and how treatment with the soluble guanylate cyclase (sGC) activator BAY 60-2770 influenced this. To create a functional model for CP, 24 male Sprague-Dawley rats were intraprostatically injected with either zymosan or saline, serving as control. After a recovery period, the rats were treated with either BAY 60-2770 or dimethyl sulfoxide (DMSO; vehicle) on days 8–20. Urine samples were collected for measurement of ATP. On day 21, the bladder was excised and contractile responses to electrical field stimulation (EFS), methacholine, ATP and nitric oxide (NO) were examined in an in vitro organ bath. Subsequently, the expression of purinergic (P2X1 & P2X3) and muscarinic (M3) receptors as well as sGC was examined immunohistochemically. Induction of CP led to significantly attenuated purinergic bladder contractions, which were normalized by treatment with BAY 60-2770. Induction of CP did not alter the contractile bladder responses to EFS, methacholine or NO. However, treatment with BAY 60-2770 led to significantly increased contractile bladder responses to EFS and MeCh and significantly enhanced relaxatory nitrergic responses. There were no significant differences between the groups regarding purinergic or cholinergic receptor expression, however treatment with BAY 60-2770 led to attenuated expression of sGC in the urothelium. Taken together, these findings indicate that drugs targeting the nitric oxide/cyclic guanosine monophosphate (NO/cGMP) pathway may be a promising option to restore alterations in bladder contractility that arise due to CP." @default.
• W4308310437 created "2022-11-10" @default.
• W4308310437 creator A5003813723 @default.
• W4308310437 creator A5014032922 @default.
• W4308310437 creator A5015910676 @default.
• W4308310437 creator A5019425736 @default.
• W4308310437 creator A5048681624 @default.
• W4308310437 creator A5052965123 @default.
• W4308310437 creator A5064715727 @default.
• W4308310437 creator A5076335226 @default.
• W4308310437 creator A5079110684 @default.
• W4308310437 creator A5079835977 @default.
• W4308310437 date "2022-12-01" @default.
• W4308310437 modified "2023-09-23" @default.
• W4308310437 title "Treatment with the soluble guanylate cyclase activator BAY 60-2770 restores in vitro bladder contractile responses in a rat model of chronic prostatitis" @default.
• W4308310437 cites W1482787294 @default.
• W4308310437 cites W1596509572 @default.
• W4308310437 cites W1725418596 @default.
• W4308310437 cites W1974479037 @default.
• W4308310437 cites W1982993995 @default.
• W4308310437 cites W2003628911 @default.
• W4308310437 cites W2022704613 @default.
• W4308310437 cites W2056609484 @default.
• W4308310437 cites W2057772772 @default.
• W4308310437 cites W2061268836 @default.
• W4308310437 cites W2067645503 @default.
• W4308310437 cites W2084464265 @default.
• W4308310437 cites W2120349925 @default.
• W4308310437 cites W2135578992 @default.
• W4308310437 cites W2141213305 @default.
• W4308310437 cites W2154765924 @default.
• W4308310437 cites W2229701246 @default.
• W4308310437 cites W2302323162 @default.
• W4308310437 cites W2317481999 @default.
• W4308310437 cites W2343695854 @default.
• W4308310437 cites W2512227072 @default.
• W4308310437 cites W2512420628 @default.
• W4308310437 cites W2619223789 @default.
• W4308310437 cites W2769822353 @default.
• W4308310437 cites W2791419854 @default.
• W4308310437 cites W2807400090 @default.
• W4308310437 cites W2840487082 @default.
• W4308310437 cites W2917812593 @default.
• W4308310437 cites W2929365543 @default.
• W4308310437 cites W2958598276 @default.
• W4308310437 cites W2978113402 @default.
• W4308310437 cites W3122757023 @default.
• W4308310437 cites W3194281767 @default.
• W4308310437 cites W3198959465 @default.
• W4308310437 cites W3203324406 @default.
• W4308310437 cites W3203961952 @default.
• W4308310437 cites W4281572768 @default.
• W4308310437 doi "https://doi.org/10.1016/j.cont.2022.100520" @default.
• W4308310437 hasPublicationYear "2022" @default.
• W4308310437 type Work @default.
• W4308310437 citedByCount "0" @default.
• W4308310437 crossrefType "journal-article" @default.
• W4308310437 hasAuthorship W4308310437A5003813723 @default.
• W4308310437 hasAuthorship W4308310437A5014032922 @default.
• W4308310437 hasAuthorship W4308310437A5015910676 @default.
• W4308310437 hasAuthorship W4308310437A5019425736 @default.
• W4308310437 hasAuthorship W4308310437A5048681624 @default.
• W4308310437 hasAuthorship W4308310437A5052965123 @default.
• W4308310437 hasAuthorship W4308310437A5064715727 @default.
• W4308310437 hasAuthorship W4308310437A5076335226 @default.
• W4308310437 hasAuthorship W4308310437A5079110684 @default.
• W4308310437 hasAuthorship W4308310437A5079835977 @default.
• W4308310437 hasConcept C126322002 @default.
• W4308310437 hasConcept C134018914 @default.
• W4308310437 hasConcept C170493617 @default.
• W4308310437 hasConcept C185592680 @default.
• W4308310437 hasConcept C22885893 @default.
• W4308310437 hasConcept C2776178081 @default.
• W4308310437 hasConcept C2777540882 @default.
• W4308310437 hasConcept C2777714996 @default.
• W4308310437 hasConcept C2779762690 @default.
• W4308310437 hasConcept C2780019924 @default.
• W4308310437 hasConcept C2780994212 @default.
• W4308310437 hasConcept C2781260171 @default.
• W4308310437 hasConcept C33789571 @default.
• W4308310437 hasConcept C519581460 @default.
• W4308310437 hasConcept C57306754 @default.
• W4308310437 hasConcept C71924100 @default.
• W4308310437 hasConcept C98274493 @default.
• W4308310437 hasConceptScore W4308310437C126322002 @default.
• W4308310437 hasConceptScore W4308310437C134018914 @default.
• W4308310437 hasConceptScore W4308310437C170493617 @default.
• W4308310437 hasConceptScore W4308310437C185592680 @default.
• W4308310437 hasConceptScore W4308310437C22885893 @default.
• W4308310437 hasConceptScore W4308310437C2776178081 @default.
• W4308310437 hasConceptScore W4308310437C2777540882 @default.
• W4308310437 hasConceptScore W4308310437C2777714996 @default.
• W4308310437 hasConceptScore W4308310437C2779762690 @default.
• W4308310437 hasConceptScore W4308310437C2780019924 @default.
• W4308310437 hasConceptScore W4308310437C2780994212 @default.
• W4308310437 hasConceptScore W4308310437C2781260171 @default.
• W4308310437 hasConceptScore W4308310437C33789571 @default.
• W4308310437 hasConceptScore W4308310437C519581460 @default.

• next